What is VVOS's market cap?

$2.24M, based on the Nov 4 close of $0.11.

Does Vivos Therapeutics pay a dividend?

No regular cash dividend has been paid in the last year.

How much of VVOS is sold short?

2.4M shares, 7.8% of float, as of Oct 15, 2026.

What sector is VVOS in?

Healthcare, in the Surgical Instruments industry.

NASDAQ · VVOSHealthcareSurgical Instruments

Vivos Therapeutics, Inc. Common Stock (VVOS)

$0.1112+1.27%

Close Nov 4, 2026 · split-adjusted

Nov 4, 2026$0.11▼ 95.29% in range

Nov 4, 2025Low $0.11 · High $2.59Nov 4, 2026

What changed · written from our data

As of Nov 4, 2026

Vivos Therapeutics closed at $0.11 on Nov 4, up 1.27%, within 2.7% of its 52-week closing low. Volume of 338.7K shares was 0.04× its 20-day average (below normal).

Split-adjusted performance: -27.7% over one month, -84.6% over six months, -95.5% over one year.

In the quarter ended Jun 30, 2026, revenue was $5.15M, up 34.9% from a year earlier, with a net margin of -106.4%.

Short interest was 2.4M shares at the Oct 15 settlement, down 17.7% from the prior report (7.8% of float, 1.0 days to cover).

Market cap$2.2M20.1M shares

Revenue · quarter$5.2M+34.9% YoY

Diluted EPS$-0.31—

P/E · TTM—P/S 0.1×

Net margin-106.4%Gross 57.3%

Dividend yieldNone

52-week range0.11 – 2.59−95.7% from high

Volume338.7K0.04× 20-day avg

Volatility · 60d89.9%Annualised

Short % of float7.8%1.0 days to cover

Net cash-$6.5MCash $1.8M

Next earnings—Not scheduled

Split-adjusted performance

1W −8.8%1M −27.7%3M −65.5%6M −84.6%YTD −94.5%1Y −95.5%3Y −97.1%5Y −99.9%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum4

Revenue growth87

Net margin22

Value (low P/E)—

Size3

Industry medians: 6-month return −4.0%, revenue growth +8.9%, net margin −8.2%, P/E 30.5×.

Short interest

Details →

Shares short2.4M−17.7% vs prior

Days to cover1.0Settled Oct 15

% of float7.8%

Short vol. 10d24.6%of daily volume

Closest peers by size in Surgical Instruments

Company	Price	Today	6M	Rev. growth	Net margin	P/E	Mkt cap
VVOSVivos Therapeutics	$0.1112	+1.27%	−84.6%	+34.9%	−106.4%	—	$2.2M
XAIRBeyond Air	$2.33	+0.43%	−79.4%	+0.5%	−448.8%	—	$2.3M	Compare
IVFINVO Fertility	$2.05	+5.67%	−71.7%	+16.7%	40.9%	—	$2.4M	Compare
ADGMAdagio Medical Holdings	$0.0862	0.00%	−91.1%	—	—	—	$2.4M	Compare
BJDXBluejay Diagnostics	$2.29	+3.62%	−69.7%	—	—	—	$2.6M	Compare
NXGLNexGel	$4.01	−10.49%	−66.6%	+27.8%	−98.6%	—	$2.0M	Compare
AMIXAutonomix Medical	$1.61	−3.01%	−80.1%	—	—	—	$3.2M	Compare
CODXCo-Diagnostics	$0.3614	−4.89%	—	+2.0%	−3782.4%	—	$3.2M	Compare
AEMDAETHLON MEDICAL	$5.75	−0.86%	−51.7%	—	—	—	$4.1M	Compare

News about Vivos Therapeutics

All news →

Vivos Therapeutics To Participate in the Small Cap Showcase & WTR Insights on June 9, 2026GlobeNewswire Inc. · Jun 8, 2026Neutral

Quick answers

What does Vivos Therapeutics do?: Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA).
What is VVOS's market cap?: $2.24M, based on the Nov 4 close of $0.11.
Does Vivos Therapeutics pay a dividend?: No regular cash dividend has been paid in the last year.
How much of VVOS is sold short?: 2.4M shares, 7.8% of float, as of Oct 15, 2026.
What sector is VVOS in?: Healthcare, in the Surgical Instruments industry.

About Vivos Therapeutics

Vivos Therapeutics Inc is a medical technology company. It is focused on the development and commercialization of a technology offering non-surgical, non-invasive, non-pharmaceutical, and low-cost solution for patients with sleep-disordered breathing (SDB), including mild-to-moderate obstructive sleep apnea (OSA). The company provides treatment for mild-to-moderate OSA involves customized oral appliances and protocols called the Vivos System. The Vivos systme is an therapeutic protocol, which often combines the use of customized oral appliance specifications and proprietary clinical treatments developed by company and prescribed by specially trained dentists in cooperation with their medical colleagues.

HQ: Littleton, CO268 employeesListed Dec 11, 2020vivos.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology